Image

Global Adipose Tissue Derived Stem Cells (ADSCS) Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Adipose Tissue Derived Stem Cells (ADSCS) Market, By Cell Line (Human Adipose Tissue-Derived Stem Cells, Rat Adipose Tissue-Derived Stem Cells), Reagents (Media, Sera, Kits), Application (Regenerative Medicine, Tissue Engineering, Cell Therapy, Others), End User (Biotechnology Companies, Academic and Research Institutes) – Industry Trends and Forecast to 2029.

Adipose Tissue Derived Stem Cells (ADSCS) Market

Adipose Tissue Derived Stem Cells (ADSCS) Market Analysis and Size

Adult stem cells, which are generated from adipose tissue, have excellent potential for regenerative therapy. The adipose tissue-derived stem cells exhibit higher yields than other stem cell sources. Skin, bone, and cartilage regeneration are a few of the regenerative medicine used for stem cells produced from adipose tissue.

Data Bridge Market Research analyses that the adipose tissue derived stem cells (ADSCS) market is expected to undergo a CAGR of 6.60% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Adipose Tissue Derived Stem Cells (ADSCS) Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Cell Line (Human Adipose Tissue-Derived Stem Cells, Rat Adipose Tissue-Derived Stem Cells), Reagents (Media, Sera, Kits), Application (Regenerative Medicine, Tissue Engineering, Cell Therapy, Others), End User (Biotechnology Companies, Academic and Research Institutes)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Lonza (U.S.), ThermoFisher Scientific Inc. (U.S.), Celprogen, Inc (U.S.), iXCells Biotechnologies (U.S.), Merck KGaA (Germany), Lifeline Cell Technology (U.S.), AlloCure, Inc. (U.S.), Antria, Inc. (U.S.), Celgene Corporation (U.S.), Cellleris SA (Spain), Corestem, Inc. (South Korea), Cytori Therapeutics, Inc. (U.S.), Intrexon, Inc. (U.S.), Mesoblast Ltd. (Australia), Pluristem Therapeutics, Inc. (Israel), and Tissue Genesis (U.S.) 

Market Opportunities

  • Rise in regulatory approvals for adipose derived stem cell
  • Rise in private and public funding for stem cell-based research

Market Definition

The stem cells from adipose tissue have a variety of uses, including research on stem cell differentiation, cell therapy, tissue engineering, and the creation of induced pluripotent stem cell lineages. These are rich in multipotent stem cells, adipocytes, osteocytes, chondrocytes, and other cell types can all be differentiated into adipocytes, osteocytes, and other cell types in vitro.

Adipose Tissue Derived Stem Cells (ADSCS) Market Dynamics

Drivers

  • Increased potential demand from the cartilage

The market for adipose tissue-derived stem cells is expanding due to the development of stem cell-based research for efficient drug manufacture and expansion in biotech applied sciences (ADSCS). When compared to other alternative stem cells such bone marrow the approach used is far more productive. The adipose tissue-derived stem cells (ADSCS) market is anticipated to have increased potential demand from the cartilage and bone regeneration industry.

  • Utilisation of reagents to provide successful results

The utilisation of reagents to provide successful results for the stem cell business will drive market expansion. Reagent kits are used in the cell line experiments performed on humans and rats. Adipose tissue-derived stem cells (ADSCS) market growth is predicted to occur between 2022 and 2029 due to a number of causes.

Opportunities

Additionally, a rise in regulatory approvals for adipose derived stem cell targeted clinical trials globally, a rise in private and public funding for stem cell-based research, and a surge in partnerships and collaborations for the development of advanced stem cell line manufacturing technologies are all contributing to the market growth for adipose tissue derived stem cells.

Restraints/Challenges

Moral objections and stringent guidelines for handling experiments may serve as market restraints during a period of market expansion. Adipose tissue-derived stem cells (ADSCS) are ineffective at distinguishing between the tissues and organs of the human body, which could impede the market's expansion.

This adipose tissue derived stem cells (ADSCS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adipose tissue derived stem cells (ADSCS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Adipose Tissue Derived Stem Cells (ADSCS) Market Scope

The adipose tissue derived stem cells (ADSCS) market is segmented on the basis of cell line, reagents, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Cell Line

  • Human Adipose Tissue-Derived Stem Cells
  • Rat Adipose Tissue-Derived Stem Cells

Reagents

  • Media
  • Sera
  • Kits

Application

  • Regenerative Medicine
  • Tissue Engineering
  • Cell Therapy
  • Others

End User

  • Biotechnology Companies
  • Academic
  • Research Institutes

Adipose Tissue Derived Stem Cells (ADSCS) Market Regional Analysis/Insights

The adipose tissue derived stem cells (ADSCS) market is analysed and market size insights and trends are provided by country, cell line, reagents, application and end user as referenced above.

The countries covered in the adipose tissue derived stem cells (ADSCS) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the adipose tissue-derived stem cells (ADSCS) market due to the amplified research and development of stem cells and tissue engineering.

Asia-Pacific (APAC) is expected to cater potential market base for adipose tissue-derived stem cells (ADSCS) due to government support in China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Adipose Tissue Derived Stem Cells (ADSCS) Market Share Analysis

The adipose tissue derived stem cells (ADSCS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to adipose tissue derived stem cells (ADSCS) market.

Some of the major players operating in the adipose tissue derived stem cells (ADSCS) market are:

  • Lonza (U.S.)
  • ThermoFisher Scientific Inc. (U.S.)
  • Celprogen, Inc (U.S.)
  • iXCells Biotechnologies (U.S.)
  • Merck KGaA (Germany)
  • Lifeline Cell Technology (U.S.)
  • AlloCure, Inc. (U.S.)
  • Antria, Inc. (U.S.)
  • Celgene Corporation (U.S.)
  • Cellleris SA (Spain)
  • Corestem, Inc. (South Korea)
  • Cytori Therapeutics, Inc. (U.S.)
  • Intrexon, Inc. (U.S.)
  • Mesoblast Ltd. (Australia)
  • Pluristem Therapeutics, Inc. (Israel)
  • Tissue Genesis (U.S.) 

Research Methodology: Global Adipose Tissue Derived Stem Cells (ADSCS) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The adipose tissue derived stem cells (ADSCS) market is projected to grow at a CAGR of 6.60% during the forecast period of 2022-2029.
Factors such as rise in regulatory approvals for adipose derived stem cell targeted clinical trials globally, a rise in private and public funding for stem cell-based research are the major growth driving factors.
The major players operating in the Adipose Tissue Derived Stem Cells (ADSCS) Market are Lonza (U.S.), ThermoFisher Scientific Inc. (U.S.), Celprogen, Inc (U.S.), iXCells Biotechnologies (U.S.), Merck KGaA (Germany), Lifeline Cell Technology (U.S.), AlloCure, Inc. (U.S.), Antria, Inc. (U.S.), Celgene Corporation (U.S.), Cellleris SA (Spain), Corestem, Inc. (South Korea), Cytori Therapeutics, Inc. (U.S.), Intrexon, Inc. (U.S.), Mesoblast Ltd. (Australia), Pluristem Therapeutics, Inc. (Israel), and Tissue Genesis (U.S.) .
The major countries covered in the Adipose Tissue Derived Stem Cells (ADSCS) Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.